Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2023
NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS from Brussel, company number BE0781668659, closed financial year 2023 with a result of € 21,774 after tax. For that financial year NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS recorded a gross margin of € 22,703 and equity of € 182,047. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 9, 2024.
€ 182,047
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 21,774
Profit after tax over the fiscal year.
€ 155,545
Cash and bank balances on the last day of the fiscal year.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 60,664
Supplier invoices still open on the last day of the fiscal year.
€ 877
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS?
What happened at NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Toby Richards stepped down as director. NBB
- Jens Meier stepped down as director. NBB
- Maria Espinosa Fernandez stepped down as director. NBB
- Maria Rondinelli stepped down as director. NBB
- Vernon Louw stepped down as director. NBB
- Patrick Meybohm stepped down as director. NBB
- Sarah Lessire stepped down as director. NBB
- Ravishankar Rao Baikady stepped down as director. NBB
A new publication or filing at NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS? We notify you, reason included.
Follow NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2023 annual accounts
Toby Richards
Director
since 2023 · until 2026
Jens Meier
Chairman of the board
since 2023 · until 2026
Maria Espinosa Fernandez
Director
since 2023 · until 2026
Maria Rondinelli
Director
since 2023 · until 2026
Vernon Louw
Director
since 2023 · until 2026
Patrick Meybohm
Director
since 2023 · until 2026
Sarah Lessire
Director
since 2023 · until 2026
Ravishankar Rao Baikady
Director
since 2023 · until 2026
Sigismond Lasocki
Chairman of the board
since 2023 · until 2026
Elvira Bisbe Vives
Director
since 2023 · until 2026
Establishments
Establishment units
Physical locations of this company
Nijverheidsstraat 24
1040 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →Société belge d'Ophtalmologie (Section francophone)
Belgisch Oftalmologissch Gezelschap, Nederlandstalige Afdeling VZW
BELGIAN GLAUCOMA SOCIETY
Organisatie van Belgische Assistenten Oftalmologie, Organisation belge des Assistants en Ophtalmologie
UNION EUROPEENNE DES MEDECINS SPECIALISTES
€ 1.6 million gross margin · 2024
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0781.668.659
- VAT number
- BE 0781.668.659
- Registered office
- Nijverheidsstraat 24, 1040 Brussel
- Names & denominations
- NETWORK FOR THE ADVANCEMENT OF PATIENT BLOOD MANAGEMENT,HAEMOSTASIS AND THROMBOSIS · NATA
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 7 February 2022
- Peppol
- Active · Active since 24 Apr 2026
- Activities · NACE
Beroepsopleiding
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Organisatie van congressen en beurzen
Overige onderwijsondersteunende dienstverlening
Overige vormen van onderwijs
Overige gespecialiseerde wetenschappelijke en technische activiteiten